Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Feb 25;25(8):1209-15.
doi: 10.1002/adma.201203824. Epub 2012 Dec 12.

A highly tunable biocompatible and multifunctional biodegradable elastomer

Affiliations

A highly tunable biocompatible and multifunctional biodegradable elastomer

Maria José Nunes Pereira et al. Adv Mater. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chemical and mechanical characterization of PGSU elastomers. A) Synthetic scheme for PGSU. B) Synthetic routes for PGSU synthesis under (i) solvent-based and (ii) solvent-free conditions. C) FTIR analysis of PGS pre-polymer and PGSU polymers synthesized under solvent-based and solvent free conditions. D) Summary of mechanical properties and degree of crosslinking for several PGSU derivatives (YM: Young’s modulus, UTS: ultimate tensile strength, El: elongation, n: crosslinking density. E) Typical stress-strain of PGSU-S films and thermally cured PGS elastomer and representative images of PGSU-S 1:0.3 films before and after tensile testing, revealing minimal creep and size/shape changes. F) Stress-strain profile of PGSU-SF 1:0.5 films during 100 cycles of tensile loading shows that the elastomer maintains its tensile properties with minimal creep.
Figure 2
Figure 2
In vivo subcutaneous and cardiac biocompatibility/biodegradation of PGSU elastomers. A) Representative images of H&E and anti-CD68 stained histological sections of the subcutaneous tissue surrounding PGSU-S 1:1 and PLGA polymers (P: polymer implant location, F: fibrous capsule). Scale bar represents 100 μm. B) Characterization of foreign body response to PGSU-S and PLGA implants through qualitative evaluation of the inflammatory infiltrate (from 0 representing no infiltrate, to 4 representing severe infiltrate). C) In vivo degradation profile of PGSU-S films implanted subcutaneously. D) Morphologic evaluation of PGSU-S 1:0.3 and 1:1 cross-sections through SEM (S: polymer surface, CS: polymer cross-section). Scale bar represents 50 μm. E) Representative images of H&E sections of cardiac tissue in contact with PGSU-SF 1:0.3 elastomer following implantation for 1 and 4 weeks (M: myocardium tissue, P: polymer implant location). D) Cardiac function before and 4 weeks after PGSU-SF implantation.
Figure 3
Figure 3
Sustained release of bioactive proteins from PGSU-SF 1:0.3 films. A) Release kinetics (i) and bioactivity (ii) of the lysozyme released from PGSU-SF 1:0.3 porous patches. B) Selective encapsulation of rhodamine and FITC intercalated in PGSU-SF 1:0.3 layers using a spin coating technique. Scale bars represent 100 μm. C) Release kinetics of the model protein BSA sieved to <75 and <32 μm particle size encapsulated within the internal layer of a trilayer spin coated PGSU-SF 1:0.3 film. D) Release kinetics of BSA co-encapsulated with the osmotic agent trehalose (1:1 ratio) and sieved to <32 μm particle size from internal and externals layers of a tri-layer spin coated PGSU-SF 1:0.3 film. Trehalose accelerates protein released by promoting increased water uptake of PGSU-SF 1:0.3 polymers.

References

    1. Serrano MC, Chung EJ, Ameer GA. Adv Funct Mater. 2010;20:192.
    1. Stuckey D, Ishii H, Chen QZ, Boccaccini A, Hansen U, Carr C, Roether J, Jawad H, Tyler D, Ali N, Clarke K, Harding S. Tissue Eng Part B. 2010;16:3395. - PubMed
    1. Wang YD, Ameer GA, Sheppard BJ, Langer R. Nat Biotechnol. 2002;20:602. - PubMed
    1. Guan J, Sacks M, Beckman E, Wagner W. Biomaterials. 2004;25:85. - PubMed
    1. Yang J, Webb AR, Ameer GA. Adv Mater. 2004;16:511.

Publication types

MeSH terms

LinkOut - more resources